Skip to content

Study · Not a test of the peptide alone · 2003

8 results

Effect of delta-sleep inducing peptide-containing preparation Deltaran on biomarkers of aging, life span and spontaneous tumor incidence in female SHR mice.

Popovich IG, Voitenkov BO, Anisimov VN, Ivanov VT, Mikhaleva II, Zabezhinski MA, Alimova IN, Baturin DA, Zavarzina NY, Rosenfeld SV, Semenchenko AV, Yashin AI

Mechanisms of ageing and development1 Jun 2003Cited by 13 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study8

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone8

In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Delta sleep-inducing peptide (DSIP).

  1. 01AnimalNot a test of Delta sleep-inducing peptide (DSIP) aloneAnimal study (in vivo)Efficacy outcome

    In female SHR mice, Deltaran did not influence mean life span.

    In plain wordsIn mice, Deltaran did not change average life span.

    Outcome
    No significant changeMean life span
    Study

    mousen = 108

    Female Swiss-derived SHR mice, treated for life
    Comparator
    Saline control
    Outcome group
    Mortality · Aging and longevity

    Source sentences

    Summary
    it did not influence mean life span; and it increased by 17.1% life span of the last 10% of the survivors and by 24.1% maximum life span in comparison with the control group.
    2 context sentences
    Summary · context
    From the age of 3 months until their natural deaths, female Swiss-derived SHR mice were subcutaneously injected 5 consecutive days every month with 0.1 ml of normal saline (control) or with 2.5 microg/mouse (approximately 100 microg/kg) of delta-sleep inducing peptide (DSIP, Trp-Ala-Gly-Gly-Asp-Ala-…
    Summary · context
    There were 54 mice in each group.

    In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Delta sleep-inducing peptide (DSIP).

  2. 02AnimalNot a test of Delta sleep-inducing peptide (DSIP) aloneAnimal study (in vivo)Efficacy outcome

    In female SHR mice, Deltaran increased the life span of the last 10% of survivors by 17.1% compared with the control group.

    In plain wordsIn mice, Deltaran lengthened the life of the longest-living tenth of animals compared with controls.

    Outcome
    IncreaseLife span of the last 10% of survivors
    Study

    mousen = 108

    Female Swiss-derived SHR mice, treated for life
    Comparator
    Saline control
    Outcome group
    Mortality · Aging and longevity

    Measurements

    Increase in life span of last 10% of survivors
    17.1%
    Deltaran vs control

    Source sentences

    Summary
    it increased by 17.1% life span of the last 10% of the survivors
    2 context sentences
    Summary · context
    From the age of 3 months until their natural deaths, female Swiss-derived SHR mice were subcutaneously injected 5 consecutive days every month with 0.1 ml of normal saline (control) or with 2.5 microg/mouse (approximately 100 microg/kg) of delta-sleep inducing peptide (DSIP, Trp-Ala-Gly-Gly-Asp-Ala-…
    Summary · context
    There were 54 mice in each group.

    In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Delta sleep-inducing peptide (DSIP).

  3. 03AnimalNot a test of Delta sleep-inducing peptide (DSIP) aloneAnimal study (in vivo)Efficacy outcome

    In female SHR mice, Deltaran increased maximum life span by 24.1% compared with the control group.

    In plain wordsIn mice, Deltaran lengthened the longest life span compared with controls.

    Outcome
    IncreaseMaximum life span
    Study

    mousen = 108

    Female Swiss-derived SHR mice, treated for life
    Comparator
    Saline control
    Outcome group
    Mortality · Aging and longevity

    Measurements

    Increase in maximum life span
    24.1%
    Deltaran vs control

    Source sentences

    Summary
    by 24.1% maximum life span in comparison with the control group.
    2 context sentences
    Summary · context
    From the age of 3 months until their natural deaths, female Swiss-derived SHR mice were subcutaneously injected 5 consecutive days every month with 0.1 ml of normal saline (control) or with 2.5 microg/mouse (approximately 100 microg/kg) of delta-sleep inducing peptide (DSIP, Trp-Ala-Gly-Gly-Asp-Ala-…
    Summary · context
    There were 54 mice in each group.

    In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Delta sleep-inducing peptide (DSIP).

  4. 04AnimalNot a test of Delta sleep-inducing peptide (DSIP) aloneAnimal study (in vivo)Efficacy outcome

    In female SHR mice, Deltaran significantly decreased total spontaneous tumor incidence by 2.6-fold compared with the control group, mainly mammary carcinomas and leukemias.

    In plain wordsIn mice, Deltaran lowered the number of spontaneous tumors compared with controls, mainly breast tumors and leukemias.

    Outcome
    DecreaseTotal spontaneous tumor incidence
    Study

    mousen = 108

    Female Swiss-derived SHR mice, treated for life
    Comparator
    Saline control
    Outcome group
    Tumor growth · Cancer

    Measurements

    Reduction in tumor incidence (fold)
    2.6 fold
    Deltaran vs control

    Source sentences

    Summary
    We also found that treatment with Deltaran significantly decreased total spontaneous tumor incidence (by 2.6-fold), mainly mammary carcinomas and leukemias in mice as compared with the control group.
    2 context sentences
    Summary · context
    From the age of 3 months until their natural deaths, female Swiss-derived SHR mice were subcutaneously injected 5 consecutive days every month with 0.1 ml of normal saline (control) or with 2.5 microg/mouse (approximately 100 microg/kg) of delta-sleep inducing peptide (DSIP, Trp-Ala-Gly-Gly-Asp-Ala-…
    Summary · context
    There were 54 mice in each group.

    In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Delta sleep-inducing peptide (DSIP).

  5. 05AnimalNot a test of Delta sleep-inducing peptide (DSIP) aloneAnimal study (in vivo)Efficacy outcome

    In female SHR mice, Deltaran did not influence food consumption.

    In plain wordsIn mice, Deltaran did not change how much they ate.

    Outcome
    No significant changeFood consumption
    Study

    mousen: not reported in source

    Female Swiss-derived SHR mice, treated for life
    Comparator
    Saline control
    Outcome group
    Appetite and food intake · Metabolic and weight

    Source sentences

    Summary
    the treatment with Deltaran did not influence food consumption
    2 context sentences
    Summary · context
    From the age of 3 months until their natural deaths, female Swiss-derived SHR mice were subcutaneously injected 5 consecutive days every month with 0.1 ml of normal saline (control) or with 2.5 microg/mouse (approximately 100 microg/kg) of delta-sleep inducing peptide (DSIP, Trp-Ala-Gly-Gly-Asp-Ala-…
    Summary · context
    There were 54 mice in each group.

    In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Delta sleep-inducing peptide (DSIP).

  6. 06AnimalNot a test of Delta sleep-inducing peptide (DSIP) aloneAnimal study (in vivo)Efficacy outcome

    In female SHR mice, Deltaran decreased body weight.

    In plain wordsIn mice, Deltaran lowered body weight.

    Outcome
    DecreaseBody weight
    Study

    mousen: not reported in source

    Female Swiss-derived SHR mice, treated for life
    Comparator
    Saline control
    Outcome group
    Body weight · Metabolic and weight

    Source sentences

    Summary
    but decreased the body weight of mice
    2 context sentences
    Summary · context
    From the age of 3 months until their natural deaths, female Swiss-derived SHR mice were subcutaneously injected 5 consecutive days every month with 0.1 ml of normal saline (control) or with 2.5 microg/mouse (approximately 100 microg/kg) of delta-sleep inducing peptide (DSIP, Trp-Ala-Gly-Gly-Asp-Ala-…
    Summary · context
    There were 54 mice in each group.

    In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Delta sleep-inducing peptide (DSIP).

  7. 07AnimalNot a test of Delta sleep-inducing peptide (DSIP) aloneAnimal study (in vivo)Efficacy outcome

    In female SHR mice, Deltaran slowed the age-related switching-off of estrous function.

    In plain wordsIn mice, Deltaran slowed the age-related loss of the estrous cycle.

    Outcome
    DecreaseAge-related switching-off of estrous function
    Study

    mousen: not reported in source

    Female Swiss-derived SHR mice, treated for life
    Comparator
    Saline control
    Outcome group
    Sex hormones and fertility · Aging and longevity

    Source sentences

    Summary
    it slowed down the age-related switching-off of estrous function
    2 context sentences
    Summary · context
    From the age of 3 months until their natural deaths, female Swiss-derived SHR mice were subcutaneously injected 5 consecutive days every month with 0.1 ml of normal saline (control) or with 2.5 microg/mouse (approximately 100 microg/kg) of delta-sleep inducing peptide (DSIP, Trp-Ala-Gly-Gly-Asp-Ala-…
    Summary · context
    There were 54 mice in each group.

    In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Delta sleep-inducing peptide (DSIP).

  8. 08AnimalNot a test of Delta sleep-inducing peptide (DSIP) aloneAnimal study (in vivo)Efficacy outcome

    In female SHR mice, Deltaran decreased the frequency of chromosome aberrations in bone marrow cells by 22.6%.

    In plain wordsIn mice, Deltaran lowered the number of chromosome changes in bone marrow cells.

    Outcome
    DecreaseChromosome aberrations in bone marrow cells
    Study

    mousen: not reported in source

    Female Swiss-derived SHR mice, treated for life
    Comparator
    Saline control
    Outcome group
    Aging markers · Aging and longevity

    Measurements

    Reduction in chromosome aberration frequency
    22.6%
    Deltaran vs control

    Source sentences

    Summary
    it decreased by 22.6% the frequency of chromosome aberrations in bone marrow cells
    2 context sentences
    Summary · context
    From the age of 3 months until their natural deaths, female Swiss-derived SHR mice were subcutaneously injected 5 consecutive days every month with 0.1 ml of normal saline (control) or with 2.5 microg/mouse (approximately 100 microg/kg) of delta-sleep inducing peptide (DSIP, Trp-Ala-Gly-Gly-Asp-Ala-…
    Summary · context
    There were 54 mice in each group.

    In this study, Delta sleep-inducing peptide (DSIP) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Delta sleep-inducing peptide (DSIP).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    9 Oct 2026, 18:17 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.